The chemicals and materials specialist Avantor (NYSE:AVTR) has acquired RIM Bio, a China-based manufacturer of single-use bioprocess bags and assemblies for biopharmaceutical applications.
The acquisition gives Avantor its first single-use production facility in Asia and doubles its global single-use cleanroom space. Avantor also has single-use manufacturing facilities in the Americas and Europe.
The RIM Bio purchase also gives Avantor access to proprietary technology for single-use products used in bioprocessing manufacturing.
RIM Bio offers an array of single-use products that it manufactures in Class 10,000 cleanrooms.
“Adding RIM Bio enables Avantor to better serve our customers by expanding our single-use manufacturing, distribution, and cleanroom capabilities to the [Asia, Middle East and Africa] AMEA region,” said Ger Brophy, EVP of biopharma production at Avantor, in a statement. “RIM serves as an anchor for us to build our presence in this key region, as we better position Avantor to capture long-term opportunities in the growing, global bioproduction space.”